Medicare Enrolled
Dr. Poonam Dulai, M.D.
Neurology · Rockville Centre, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dulai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dulai?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dulai
Dr. Poonam Dulai is a neurology specialist in Rockville Centre, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dulai performed 5,509 Medicare services across 2,125 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dulai received a total of $9,513 from 62 pharmaceutical and/or device companies across 493 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dulai is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 12% volume in NY
$9,513 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,509
Medicare services
Top 12% in NY for neurology
2,125
Unique beneficiaries
$112
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~290 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,681 | $72 | $150 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,531 | $109 | $220 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
569 | $158 | $400 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
439 | $159 | $335 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
376 | $197 | $675 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
371 | $46 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
224 | $115 | $230 |
| New patient office visit, complex (60-74 min) | 83 | $195 | $490 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
56 | $91 | $250 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
38 | $81 | $220 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
32 | $363 | $850 |
| Mental processes therapy, initial 15 minutes A therapy session focusing on a range of mental processes, lasting for the initial 15 minutes. |
32 | $19 | $75 |
| Digital analysis of brain wave activity (EEG) This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision. |
31 | $260 | $600 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $155 | $390 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
17 | $196 | $390 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
11 | $229 | $460 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,513
Total received (2018-2024)
Avg $1,359/year across 7 years
Top 25% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
493
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,174 (96.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$339 (3.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,441
2023
$1,427
2022
$1,558
2021
$1,506
2020
$871
2019
$1,307
2018
$1,403
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ACADIA Pharmaceuticals Inc
$175
Amneal Pharmaceuticals LLC
$154
Biogen, Inc.
$152
Eisai Inc.
$128
MDD US Operations, LLC
$126
Medtronic, Inc.
$118
ABBVIE INC.
$75
Azurity Pharmaceuticals, Inc.
$73
Celgene Corporation
$68
EMD Serono, Inc.
$60
Lilly USA, LLC
$57
Lundbeck LLC
$52
ARGENX US, INC.
$45
PFIZER INC.
$32
Amgen Inc.
$31
Otsuka Pharmaceutical Development & Commercialization, Inc.
$30
Alnylam Pharmaceuticals Inc.
$26
Otsuka America Pharmaceutical, Inc.
$23
Acorda Therapeutics, Inc
$16
Top 3 companies account for 33.4% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$1,241
ACADIA Pharmaceuticals Inc
$773
UCB, Inc.
$524
EMD Serono, Inc.
$369
Lundbeck LLC
$352
Medtronic, Inc.
$302
Amneal Pharmaceuticals LLC
$297
ABBVIE INC.
$294
Lilly USA, LLC
$276
AbbVie Inc.
$266
Adamas Pharmaceuticals, Inc.
$245
Novartis Pharmaceuticals Corporation
$243
Acorda Therapeutics, Inc
$232
ARBOR PHARMACEUTICALS, INC.
$220
GENZYME CORPORATION
$216
Almatica Pharma LLC
$212
Sunovion Pharmaceuticals Inc.
$189
Janssen Pharmaceuticals, Inc
$179
Eisai Inc.
$170
Biohaven Pharmaceuticals, Inc.
$163
Neurocrine Biosciences, Inc.
$152
Biohaven Pharmaceutical Holding Company Ltd.
$152
Horizon Therapeutics plc
$151
MDD US Operations, LLC
$145
Allergan Inc.
$128
Alexion Pharmaceuticals, Inc.
$128
Radius Health, Inc.
$120
Arbor Pharmaceuticals, Inc.
$111
Celgene Corporation
$102
Neurelis, Inc.
$98
GE HEALTHCARE
$98
Supernus Pharmaceuticals, Inc.
$90
GE Healthcare
$88
Azurity Pharmaceuticals, Inc.
$73
Avanir Pharmaceuticals, Inc.
$72
PFIZER INC.
$68
Allergan, Inc.
$63
US WorldMeds, LLC
$63
SK Life Science, Inc.
$59
Otsuka Pharmaceutical Development & Commercialization, Inc.
$59
Teva Pharmaceuticals USA, Inc.
$59
Kyowa Kirin, Inc.
$58
Otsuka America Pharmaceutical, Inc.
$56
Amgen Inc.
$55
Alfasigma USA, Inc.
$50
ASSERTIO THERAPEUTICS, Inc.
$49
ARGENX US, INC.
$45
Impax Laboratories, Inc.
$43
E.R. Squibb & Sons, L.L.C.
$39
Assertio Therapeutics, Inc.
$36
Grifols USA, LLC
$29
Alnylam Pharmaceuticals Inc.
$26
LivaNova USA, Inc.
$23
Bayer HealthCare Pharmaceuticals Inc.
$22
Medtronic USA, Inc.
$22
Amylyx Pharmaceuticals, Inc.
$21
IMPEL PHARMACEUTICALS INC.
$20
Avion Pharmaceuticals
$19
UPSHER-SMITH LABORATORIES LLC
$16
Piramal Imaging Limited
$15
BANNER LIFE SCIENCES, LLC
$14
Promius Pharma LLC
$14
Top 3 companies account for 26.7% of all-time payments
Associated products mentioned in payments ›
ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AVONEX · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · CREXONT · Cambia · Dhivy · EMGALITY · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gocovri · Gralise · HORIZANT · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · Leqembi · MAVENCLAD · Mavenclad · NAMZARIC · NAPRELAN · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · OXTELLAR XR · PERCEPT PC BRAINSENSE · PLEGRIDY · Percept · Ponvory · QULIPTA · RELYVRIO · REXULTI · RYTARY · Rebif · SOLIRIS · Soliris · TECFIDERA · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · Tymlos · UBRELVY · UPLIZNA · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · Vimpat · Xadago · ZEPOSIA · Zembrace · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
1,083
Per 100K population
78.0
County median income
$143,408
Nearest hospital
MOUNT SINAI SOUTH NASSAU
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dulai is a mixed practice specialist, with above-average Medicare volume (top 12% in NY), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dulai experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Dulai performed 1,681 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dulai receive payments from pharmaceutical companies?
Yes. Dr. Dulai received a total of $9,513 from 62 companies across 493 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dulai's costs compare to other neurologists in Rockville Centre?
Dr. Dulai's average Medicare payment per service is $112. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dulai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Rockville Centre
Browse neurologists in Rockville Centre ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
ACADIA Pharmaceuticals Inc Payments to Doctors
See all physicians who received payments from ACADIA Pharmaceuticals Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology